PT  - JOURNAL ARTICLE
AU  - Ana Carolina Reis Tadeu
AU  - Inês Rosendo Carvalho e Silva Caetano
AU  - Inês Jorge de Figueiredo
AU  - Luiz Miguel Santiago
TI  - “Multimorbidity and consultation time: a systematic review”
AID  - 10.1101/19007328
DP  - 2019 Jan 01
TA  - medRxiv
PG  - 19007328
4099  - http://medrxiv.org/content/early/2019/09/23/19007328.short
4100  - http://medrxiv.org/content/early/2019/09/23/19007328.full
AB  - Background Multimorbidity (MM) is one of the major challenges health systems currently face. Management of time length of a medical consultation with a patient with MM is a matter of concern for doctors.Objectives To describe the impact of MM on the average time of a medical consultation.Methods A systematic review was performed considering the Preferred Reporting Items for Systematic Review and Meta-analyses (PRISMA) guidelines. The systematic online searches of the Embase and PubMed databases were undertaken, from January 2000 to August 2018. The studies were independently screened by two reviewers to decide which ones met the inclusion criteria. (Kappa=0.84 and Kappa=0.82). Differing opinions were solved by a third person. This systematic review included people with MM criteria as participants (two or more chronic conditions in the same individual). The type of outcome included was explicitly defined – the length of medical appointments with patients with MM. Any strategies aiming to analyse the impact of MM on the average consultation time were considered. The length of time of medical appointment for patients without MM was the comparator criteria. Experimental and observational studies were included.Results Of 85 articles identified, only 1 observational study was included, showing a clear trend for patients with MM to have longer consultations than patients without MM criteria (p<0.001).Conclusions More studies are necessary to assess better allocation length-time for patients with MM and to measure other characteristics like doctors workload.Competing Interest StatementThe authors have declared no competing interest.Clinical Trial#006536Funding Statementno external funding was receivedAuthor DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.Not ApplicableAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesAll data will be available upon requestMMMultimorbidityGPGeneral PractitionerPRISMAPreferred Reporting Items for Systematic Review and Meta-analysesHSHealth ServiceWHOWorld Health Organization